IRadimed Corporation (IRMD) financial statements and ratios from SEC XBRL: revenue $83.81M (TTM), net margin 26.8%, revenue growth 14.4% YoY, P/E 49.5. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $83.81M |
| Net Margin | 26.8% |
| Revenue Growth (YoY) | 14.4% |
| EPS Growth (YoY) | 16.4% |
| FCF Growth (YoY) | -2.5% |
| P/E Ratio | 49.5 |
| EV / EBITDA | 36.0 |
| Price / Book | 10.90 |
| Price / Sales | 12.96 |
| FCF Yield | 3.7% |
| DCF Value (model) | $73.94 |
| DCF Upside vs Price | -14.8% |
| Altman Z-Score | 50.17 (safe) |
| Sector P/E (Healthcare) | 21.6 |
IRMD overview · IRMD earnings · IRMD KPIs · IRMD investor relations · IRMD ownership · IRMD peers · IRMD filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.